신고사유
신고해주신 내용은 쇼핑몰 운영자의 검토 후 내부 운영 정책에 의해 처리가 진행됩니다.
Brief Description | Inhibits acetylcholinesterase (IC50 = 4.09 μM) and reduce Aβ peptide generation; Inhibits STAT3 activity (IC50 = 4.6 μM) |
---|---|
Purity | 0.98 |
Appearance | Orange solid |
Synonyms | (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; Cryptotanshinone; 35825-57-1; (R)-1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl-phenanthro(1,2-b)furan-10,11-dione; UNII-5E9SXT166N; MLS001049002; SMR000387041; (1r)-1,6,6-trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; Cryptotanshinon; Tanshinone c; NSC686518; (-)-Cryptotanshinone; S2285_Selleck; AC1Q6JLL; AC1L4NB8; SPECTRUM1505812; 5E9SXT166N; CHEMBL187460; cid_160254; SCHEMBL5940386; BDBM57938; CTK4I9862; Phenanthro(1,2-b)furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-; BB_NC-1574; HMS2269A22; KST-1A5761; KST-1A5762; HY-N0174; ZINC2109876; ANW-46875; AR-1A1000; AR-1A1001; MFCD07636810; ZINC02109876; AKOS015895392; BCP9000554; CCG-208561; CS-3276; MCULE-9919031730; NSC-686518; NCGC00163650-01; NCGC00163650-02; AJ-33498; AK-34832; CJ-32830; DR001155; NCI60_031208; PL018869; BCP0726000307; KB-209580; LS-193719; ST2414407; TR-014774; FT-0603171; N1843; W2147; Cryptotanshinone-Supplied by Selleck Chemicals; Q-100429; Phenanthro[1,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g]benzofuran-10,11-dione; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g]benzofuran-10,11-quinone; (R)-(-)-1,6,6-Trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione; (R)-1,2,6,7,8,9-Hexahydro-1,6,6-trimethylphenanthro[1,2-b]furan-10,11-dione; (R)-1,6,6-trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl- (R)-phenanthro(1,2-b)furan-10,11-dione; Cryptotanshinone|1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl[1,2-b]furan-10,11-dione; Phenanthro[1,2-b]furan-10,11-dione,1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-; (14R)-6,6,14-TRIMETHYL-12-OXATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(10),2(7),8,11(15)-TETRAENE-16,17-DIONE; (14R)-6,6,14-trimethyl-12-oxatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),2(7),8,11(15)-tetraene-16,17-dione; (14R)-6,6,14-trimethyl-12-oxatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),2(7),8,11(15)-tetraene-16,17-dione |
Solubility | Soluble to 10 mM in DMSO |
Storage | Store in a cool and dry place and at 0 - 4℃ for short term (days to weeks) or -35℃ for long term (months to years). |
Application | Implicated in Alzheimer's disease |
Quality Standard | Enterprise Standard |
게시물이 없습니다
게시물이 없습니다